Urology

Researchers from the University of Laval surveyed men to find out their preferences for consultation.

Prostate cancer remains the most commonly diagnosed non-skin cancer among Canadian men and is the third leading cause of cancer-related death.

A recent study pinpointed certain communication pitfalls that result in patients interpreting their doctors' explanations as the exact opposite.

Dr. Cristian Lucian Budeci should have rushed his 14-year-patient to a urologist, ruled the Collège des médecins du Québec. Instead he prescribed antibiotics and over-the-counter painkillers.

The treatment is approved for patients who have a moderate to high risk of recurrence, following nephrectomy or nephrectomy accompanied by surgical resection of metastatic lesions.

Lead a multidisciplinary panel to identify clinically important cascades consistent with potentially inappropriate prescribing.

It is estimated that in 2022, 24,600 Canadians will be diagnosed with prostate cancer, and 4,600 Canadians will die from it. This represents 10% of male cancer deaths in the country.

The new treatment is indicated for men who have previously received at least one androgen receptor signaling pathway inhibitor and taxane-based chemotherapy.